What this means
Older adults on insulin can have dangerous drops in blood sugar. This trial plans to test a program that uses glucose monitors and teaching to lower that risk. The trial is still recruiting, so it has no results yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 75 and over
- Where
- 6 sites, including California
The science
- Registered title
- Safer Aging With Diabetes Monitoring
- Trial ID
- NCT06296485 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Diabetes Mellitus, Type 2, Hypoglycemia
- What is tested
- SAGE Group Sessions, Usual Care
- Sponsor
- Kaiser Permanente
- Ages
- 75 Years to no maximum
- Dates
- First posted Mar 6, 2024 · updated Aug 4, 2026
Registry summary
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Sites (6)
- Kaiser Permanente Fremont, Fremont, California, United States
- Kaiser Permanente Sacramento, Sacramento, California, United States
- Kaiser Permanente San Jose, San Jose, California, United States
- Kaiser Permanente San Leandro, San Leandro, California, United States
- Kaiser Permanente Santa Clara, Santa Clara, California, United States
- Kaiser Permanente - Union City, Union City, California, United States